Yield10 Bioscience announced that the Company has begun its winter 2022/2023 field test and seed production program for Camelina at sites in the United States, Canada, Argentina and Chile. Yield10’s winter 2022/2023 field test program, which is being conducted at more than 20 sites, is intended to evaluate several varieties of elite Camelina by collecting data on agronomical performance, seed yield, oil content, and herbicide tolerance, where applicable. Herbicide Tolerance: Yield10 is conducting contra-season field tests of candidate herbicide tolerance traits in Camelina. Yield10 has selected potential commercial events of Camelina lines displaying herbicide tolerance and will evaluate field performance and conduct seed scale-up activities for producing seed for larger field tests planned for spring 2023. Agronomy Trials: Yield10 will conduct agronomy trials of winter Camelina varieties as part of a program to develop standardized protocols to achieve the best germination, stand establishment and yields. Commercial Seed Production: Yield10 has contracted with growers to plant Camelina varieties E3902, WDH3 and WDH2 to produce commercial seed. Demonstration Fields: As part of its market development efforts, Yield10 has planted winter Camelina in fields suitable for hosting grower events in 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on YTEN:
- Yield10 Bioscience Begins Winter 2022/2023 Field Test and Seed Production Program
- Yield10 Bioscience to Announce Third Quarter 2022 Financial Results and Host a Conference Call on Monday, November 14, 2022
- Yield10 Bioscience Appoints Willie Loh, Ph.D., Former Cargill Executive, to the Board of Directors
- Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the ISBP 2022 Conference